Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV6 | Q9H1D0 | 4/20 | 0.47 |
| ▸ | ORAI1 | Q96D31 | 3/20 | 0.47 |
| ▸ | ORAI2 | Q96SN7 | 3/20 | 0.47 |
| ▸ | ORAI3 | Q9BRQ5 | 3/20 | 0.47 |
| ▸ | CA4 | P22748 | 3/20 | 0.47 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | MGLL | Q99685 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8966944 | 0.86 | ORAI1 (0.42) | TRPV6ORAI1ORAI2ORAI3CA4 | |
| SCHEMBL23533754 | 0.86 | MGLL (0.54) | TRPV6ORAI1ORAI2ORAI3CA4 | |
| SCHEMBL115344 | 0.79 | — | — | |
| SCHEMBL9856793 | 0.73 | — | — | |
| SCHEMBL14605173 | 0.73 | — | — | |
| SCHEMBL125450 | 0.69 | TRPV6 (0.53) | TRPV6ORAI1ORAI2ORAI3CA4 | |
| SCHEMBL8966469 | 0.67 | ORAI1 (0.38) | TRPV6ORAI1ORAI2ORAI3CA4 | |
| SCHEMBL7455323 | 0.67 | CA2 (0.52) | TRPV6ORAI1ORAI2ORAI3CA7 | |
| SCHEMBL11103898 | 0.67 | TRPV6 (0.50) | TRPV6ORAI1ORAI2ORAI3CA4 | |
| Ammonia Solution, Strong SCHEMBL475909 | 0.67 | TRPV6 (0.50) | TRPV6ORAI1ORAI2ORAI3CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108409766-A | The preparation method of a kind of boracic nitrogen small molecule and conjugated polymer and to fluorine ion sensing application | 西安交通大学 | 2018-08-17 | — | — | CN | claimed |
| WO-2009084037-A2 | NOVEL PROCESS FOR PREPARATION OF O-DESMETHYLVENLAFAXINE | CALYX CHEMICALS AND PHARMACEUTICALS LTD. (IN) | 2009-07-09 | — | — | WO | claimed |
| US-4199021-A | Thermal energy storage apparatus | JOHNSON CONTROLS, INC. (US) | 1980-04-22 | — | — | US | claimed |
| US-20240254146-A1 | FLUORINATED POLY(PYRIDYL)-BORATE LIGANDS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2024-08-01 | — | — | US | disclosed |
| CN-111377952-B | Compound, application thereof and organic electroluminescent device comprising compound | 北京鼎材科技有限公司 | 2022-11-15 | — | — | CN | disclosed |
| CN-110894203-B | Organic light-emitting compound, application thereof and organic electroluminescent device | 北京绿人科技有限责任公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-110267993-B | Microstructure controlled ethylene and C3-C10Alpha-olefin copolymer | 雅富顿化学公司 | 2022-07-08 | — | — | CN | disclosed |
| US-11091613-B2 | Microstructure-controlled copolymers of ethylene and C3-C10 alpha-olefins | AFTON CHEMICAL CORPORATION (US) | 2021-08-17 | — | — | US | disclosed |
| US-20210171678-A1 | MICROSTRUCTURE-CONTROLLED COPOLYMERS OF ETHYLENE AND C3-C10 ALPHA-OLEFINS | AFTON CHEMICAL CORPORATION (US) | 2021-06-10 | — | — | US | disclosed |
| CN-110272410-B | Compound, luminescent material, organic photoelectric device and electronic equipment | 上海天马有机发光显示技术有限公司 | 2021-03-23 | — | — | CN | disclosed |
| EP-3755731-A1 | MICROSTRUCTURE-CONTROLLED COPOLYMERS OF ETHYLENE AND C3-C10 ALPHA-OLEFINS | Afton Chemical Corporation (US) | 2020-12-30 | — | — | EP | disclosed |
| EP-0519496-A1 | Thermosetting copolymers, silicon carbide-based fiber and processes for producing same | Tonen Corporation (JP) | 1992-12-23 | — | — | EP | disclosed |
| EP-0389084-A2 | Process for producing a polyborosilazane | Tonen Corporation (JP) | 1990-09-26 | — | — | EP | disclosed |
| US-4900854-A | Process for the preparation of asymmetrical alkaline earth metal organoborates, organoaluminates, organoarsenates, and organophosphates | THE DOW CHEMICAL COMPANY (US) | 1990-02-13 | — | — | US | disclosed |
| US-4199021-A | Thermal energy storage apparatus | JOHNSON CONTROLS, INC. (US) | 1980-04-22 | — | — | US | disclosed |
| US-4199021-A | Thermal energy storage apparatus | JOHNSON CONTROLS, INC. (US) | 1980-04-22 | — | — | US | disclosed |
| US-4161571-A | GELATION INHIBITORS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1979-07-17 | — | — | US | disclosed |
| US-4080493-A | POLYBUTADIENE, POLYISOPRENE, GELATION INHIBITOR | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1978-03-21 | — | — | US | disclosed |
| US-4054612-A | HOMO- OR COPOLYMERIZATION OF BUTADIENE, CATALYTIC | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-10-18 | — | — | US | disclosed |
| US-4052473-A | OF ISOPRENE, NICKEL-ALKYLAMUMIN HALIDE CONTAINING CATALYST | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240254146-A1 | FLUORINATED POLY(PYRIDYL)-BORATE LIGANDS | PARG, PARN, PCBP1 | TRPV6 1123/4885ORAI1 3799/4885ORAI2 4491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.